Our specialty and biosimilar products
We are guided by a desire to enable people to have greater control over their health and live life to its fullest potential. A steadfast commitment to our patients runs to the heart of everything we do, and our high-quality products make a difference in the lives of thousands of Canadians, every day.
Should you have any questions about our products, please do not hesitate to contact us. Our Customer Care department can be reached at (416) 291-8888 ext. 5750 (during regular business hours) or ext. 5216 (after regular business hours).
Note: Canadian regulations limit the scope of information we are permitted to provide in relation to prescription drugs. Please consult with your healthcare professional for more detailed information on any of our products.
55 mcg/actuation, 113 mcg/actuation and 232 mcg/actuation
02467895 (55 mcg/actuation); 02467909 (113 mcg/actuation); 02467917 (232 mcg/actuation)
To view the Aermony RespiClick™ (fluticasone propionate) product monograph, click here.
For more information on how to use Aermony RespiClickTM, please view the video below.
Solution for subcutaneous injection.
225 mg/mL solution in a single-dose prefilled syringe
225 mg/mL solution in a single-dose prefilled autoinjector
225 mg (1 subcutaneous injection) once a month – monthly dosing, or
675 mg (3 separate subcutaneous injections of 225mg each) once every 3 months – quarterly dosing
02497859 (single-dose prefilled syringe)
02509474 (single-dose prefilled autoinjector)
To view the AJOVY™ (fremanezumab) Product Monograph, click here
0.5 mg and 1 mg tablets
02284642 (0.5 mg); 02284650 (1.0 mg)
20 mg/mL and 40 mg/mL
02245619 (20 mg); 02456915 (40 mg)
100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg
02408007 (100 mcg); 02408015 (200 mcg); 02408023 (400 mcg); 02408031 (600 mcg); 02408058 (800 mcg)
To view the Fentora™ Product Monograph, click here
To view the Fentora™ Guide for Prescribers, click here
To view the Fentora™ Guide for Patients & Caregivers, click here
1.5 mg NA and 30 µg EE Tablets
00297143 (21-day pack); 00353027 (28-day pack)
To view the Loestrin® 21-day pack Product Monograph, click here
To view the Loestrin® 28-day pack Product Monograph, click here
1 mg NA and 20 µg EE Tablets
00315966 (21-day pack); 00343838 (28-day pack)
To view the Minestrin® 21-day pack Product Monograph, click here
To view the Minestrin® 28-day pack Product Monograph, click here
0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol per tablet
0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol and 0.01 mg ethinyl estradiol per tablet
25 mg/vial and 100 mg/vial
02392550 (25 mg/vial); 02392569 (100 mg/vial)
To view the Treanda® Product Monograph, click here
To view the Treanda® Guide for Patients & Caregivers, click here
Important Safety Information on Trisenox® for health care professionals – 2 Formulations
12 mg/6 ml (2 mg/mL) stoppered vial
02407833 (1mg/ml vial)
To view the Trisenox® Product Monograph, click here
To view the Trisenox® Guide for Patients & Caregivers, click here
To view the Herzuma® Product Monograph, click here
To view the Herzuma® Guide for Patients & Caregivers, click here
100 mg/10 mL, 500 mg/50 mL
To view the Truxima™ Product Monograph, click here
To view the Truxima™ Guide for Patients & Caregivers, click here
We know that every one of our products will have an impact on another individual’s health. Our dedication to quality in everything we do is uncompromising, and covers every stage of the development, production, marketing and distribution of our medicines: from the supply of materials to manufacturing and obtaining approval by Health Canada.
We never rest on our laurels, and our passion for excellence drives us to continually improve practices, processes and procedures.